GINMU >
01 奈良県立医科大学 >
011 医学部 >
0112 紀要 >
01121 Journal of Nara Medical Association >
Vol.43 No.5 >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10564/1867
|
Title: | Enzyme-Linked Immunosorbent Assayによる第Ⅷ因子抑制物質中のIgG subclassの検討 |
Other Titles: | ANALYSIS OF IgG SUBCLASS IN FACTOR Ⅷ INHIBITOR BY ENZYME-LINKED IMMUNOSORBENT ASSAY |
Authors: | 澤本, 好克 |
Keywords: | hemophilia A factor Ⅷ (F. Ⅷ) inhibitor IgG subclass enzyme-linked immunosorbent assay (ELISA) |
Issue Date: | 31-Oct-1992 |
Publisher: | 奈良医学会 |
Citation: | 奈良医学雑誌 Vol.43 No.5 p.511-521 |
Abstract: | Semi-quantitative analysis for factor Ⅷ (F. Ⅷ)-specific IgG subclass in the plasma of hemophilia A with F. Ⅷ inhibitor was developed by enzyme-linked immunosorbent
assay (ELISA) using immobilized recombinant F. Ⅷ. The bound F. Ⅷ-specific IgG subclass was detected by monoclonal anti-IgG₁, IgG₂, IgG₃ and IgG₄ antibodies followed
by peroxidase conjugated goat anti-mouse IgG. Out of 82 plasma samples from 14 patients with inhibitor, 53 samples from 11 patients were positive for only IgG₄. There was no sample which was positive for only IgG₁, IgG₂ or IgG₃. Of the eleven patients with samples which were positive for only IgG₄, one patient was also positive for only IgG₁ in one sample, four patients were also positive for only IgG₂ in eight samples and one patient was positive
for only IgG₃ in three samples on different dates. None of F. Ⅷ-specific IgG subclass was detected in the plasma from 27 samples of hemophilia A without inhibitor. In conclusion, the ELISA system was suitable not only for the detection of F. Ⅷ inhibitor but also for semi-quantitative estimation of changes in the plasma content of F. Ⅷ-specific IgG subclass. Furthermore, it was demonstrated that the dominant subclass among the inhibitors was IgG₄. However, other IgG subclasses were also detected in some cases. |
URI: | http://hdl.handle.net/10564/1867 |
ISSN: | 04695550 13450069 |
Appears in Collections: | Vol.43 No.5
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|